Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Daiichi Sankyo
Day One Biopharmaceuticals, Inc.
Merck Sharp & Dohme LLC
Telix Pharmaceuticals (Innovations) Pty Limited
Elevation Oncology
Merck Sharp & Dohme LLC
Endocyte
Jules Bordet Institute
Seagen Inc.
National Institutes of Health Clinical Center (CC)
Wake Forest University Health Sciences
Roswell Park Cancer Institute
Dana-Farber Cancer Institute
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)
M.D. Anderson Cancer Center